{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:48:21Z","timestamp":1795139301400,"version":"4.10.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Health","award":["NIHCD 1R01H087993"],"award-info":[{"award-number":["NIHCD 1R01H087993"]}]},{"name":"National Institute of Health","award":["NIAID K08AI148607"],"award-info":[{"award-number":["NIAID K08AI148607"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["glob health res policy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite global efforts to reduce preventable childhood illness by distributing infant vaccines, immunization coverage in sub-Saharan African settings remains low. Further, timely administration of vaccines at birth\u2014tuberculosis (Bacille Calmette\u2013Gu\u00e9rin [BCG]) and polio (OPV0)\u2014remains inconsistent. As countries such as Democratic Republic of the Congo (DRC) prepare to add yet another birth-dose vaccine to their immunization schedule, this study aims to improve current and future birth-dose immunization coverage by understanding the determinants of infants receiving vaccinations within the national timeframe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study used two ordered regression models to assess barriers to timely BCG and first round of the hepatitis B (HepB3) immunization series across multiple time points using the Andersen Behavioral Model to conceptualize determinants at various levels. The assessment leveraged survey data collected during a continuous quality improvement study (NCT03048669) conducted in 105 maternity centers throughout Kinshasa Province, DRC. The final sample included 2398 (BCG analysis) and 2268 (HepB3 analysis) women-infant dyads living with HIV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 2016 and 2020, 1981 infants (82.6%) received the BCG vaccine, and 1551 (68.4%) received the first dose of HepB3 vaccine. Of those who received the BCG vaccine, 26.3%, 43.5%, and 12.8% received BCG within 24\u00a0h, between one and seven days, and between one and 14\u00a0weeks, respectively. Of infants who received the HepB3 vaccine, 22.4% received it within six weeks, and 46% between six and 14\u00a0weeks of life. Many factors were positively associated with BCG uptake, including higher maternal education, household wealth, higher facility general readiness score, and religious-affiliated facility ownership. The factors influencing HepB3 uptake included older maternal age, higher education level, household wealth, transport by taxi to a facility, higher facility general and immunization readiness scores, and religious-affiliated facility ownership.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrated that the study participants\u2019 uptake of vaccines was consistent with the country average, but not in a timely manner. Various factors were associated with timely uptake of BCG and HepB3 vaccines. These findings suggest that investment to strengthen the vaccine delivery system might improve timely vaccine uptake and equity in vaccine coverage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41256-023-00338-7","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T04:02:34Z","timestamp":1701835354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Childhood immunization uptake determinants in Kinshasa, Democratic\u00a0Republic of the\u00a0Congo: ordered regressions to assess timely infant vaccines administered at birth and 6-weeks"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6180-1931","authenticated-orcid":false,"given":"Alix","family":"Boisson-Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Michael","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ngimbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fid\u00e9le","family":"Lumande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Tabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchior Mwandagalirwa","family":"Kashamuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9lagie","family":"Babakazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa Elaine","family":"Domino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Yotebieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"338_CR1","unstructured":"Centers for Disease Control and Prevention (CDC). Pink Book, Chapter 10: Hepatitis B. 14th ed. 2021."},{"key":"338_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/bmj.314.7086.1033","volume":"314","author":"P Van Damme","year":"1997","unstructured":"Van Damme P, Kane M, Andre M. Integration of hepatitis B vaccination into national immunisation programmes. Br Med J. 1997;314:1033\u20135.","journal-title":"Br Med J"},{"issue":"1","key":"338_CR3","first-page":"24","volume":"23","author":"G Fran\u00e7ois","year":"2008","unstructured":"Fran\u00e7ois G, Dochez C, Jeffrey Mphahlele M, Burnett R, Van Hal G, Meheus A. Hepatitis B vaccination in Africa: mission accomplished? South Afr J Epidemiol Infect. 2008;23(1):24\u20138.","journal-title":"South Afr J Epidemiol Infect"},{"issue":"Supp 3","key":"338_CR4","first-page":"17","volume":"27","author":"L Breakwell","year":"2017","unstructured":"Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R. The status of hepatitis B control in the African region. PanAfrican Med J. 2017;27(Supp 3):17.","journal-title":"PanAfrican Med J"},{"issue":"Supp 3:18","key":"338_CR5","first-page":"1","volume":"27","author":"CR Tamandjou","year":"2017","unstructured":"Tamandjou CR, Maponga TG, Chotun N, Preiser W, Andersson MI. Is hepatitis B birth dose vaccine needed in Africa? The PanAfrican Medical journal. 2017;27(Supp 3:18):1\u20133.","journal-title":"The PanAfrican Medical journal."},{"issue":"2","key":"338_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1017\/S0950268800001497","volume":"117","author":"WJ Edmunds","year":"1996","unstructured":"Edmunds WJ, Medley GF, Nokes DJ, O\u2019Callaghan CJ, Whittle HC, Hall AJ. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr. Epidemiol Infect. 1996;117(2):313\u201325.","journal-title":"Epidemiol Infect"},{"issue":"22","key":"338_CR7","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1001\/jama.1989.03420220092033","volume":"261","author":"Y Poovorawan","year":"1989","unstructured":"Poovorawan Y, Sanpavat S, Pongpunlert W, Chumdermpadetsuk S, Sentrakul P, Safary A. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen: positive mothers. JAMA. 1989;261(22):3278\u201381.","journal-title":"JAMA"},{"issue":"8383","key":"338_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(84)92388-2","volume":"1","author":"VCW Wong","year":"1984","unstructured":"Wong VCW, Reesink HW, Ip HMH, Nco Lelie P, Reerink-Brongers EE, Yeung CY, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. The Lancet. 1984;1(8383):921\u20136.","journal-title":"The Lancet"},{"issue":"1","key":"338_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13031-019-0188-y","volume":"13","author":"JM Reardon","year":"2019","unstructured":"Reardon JM, O\u2019Connor SM, Njau JD, Lam EK, Staton CA, Cookson ST. Cost-effectiveness of birth-dose hepatitis B vaccination among refugee populations in the African region: a series of case studies. Confl Health. 2019;13(1):1\u201310.","journal-title":"Confl Health."},{"issue":"4","key":"338_CR10","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1016\/S2214-109X(22)00026-2","volume":"10","author":"Y Shimakawa","year":"2022","unstructured":"Shimakawa Y, Veillon P, Birguel J, Pivert A, Sauvage V, Le G-G, et al. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study. Lancet Glob Health. 2022;10(4):e521\u20139.","journal-title":"Lancet Glob Health"},{"key":"338_CR11","unstructured":"World Health Organization. Practices to improve coverage of the hepatitis B birth dose vaccine. Immunization, vaccines, and biologicals. 2013."},{"key":"338_CR12","unstructured":"World Health Organization. Preventing perinatal hepatitis B virus transmission: a guide for introducing and strengthening hepatitis B birth dose vaccination. 2015."},{"key":"338_CR13","unstructured":"Njuguna H. Building toward a future of african children free of HBV infection: hepatitis B virus infection in Africa. In 2021."},{"issue":"1","key":"338_CR14","first-page":"1","volume":"10","author":"A Boisson","year":"2020","unstructured":"Boisson A, Goel V, Yotebieng M, Parr JB, Fried B, Thompson P. Implementation approaches for introducing and overcoming barriers to hepatitis B birth-dose vaccine in sub-Saharan Africa. Glob Health Sci Pract. 2020;10(1):1\u201314.","journal-title":"Glob Health Sci Pract"},{"issue":"4","key":"338_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/jvh.13231","volume":"27","author":"S Nayagam","year":"2020","unstructured":"Nayagam S, Shimakawa Y, Lemoine M. Mother-to-child transmission of hepatitis B: What more needs to be done to eliminate it around the world? J Viral Hepat. 2020;27(4):342\u20139.","journal-title":"J Viral Hepat"},{"issue":"29","key":"338_CR16","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1016\/j.vaccine.2016.05.017","volume":"34","author":"R Miyahara","year":"2016","unstructured":"Miyahara R, Jasseh M, Gomez P, Shimakawa Y, Greenwood B, Keita K, et al. Barriers to timely administration of birth dose vaccines in The Gambia, West Africa. Vaccine. 2016;34(29):3335\u201341.","journal-title":"Vaccine"},{"key":"338_CR17","first-page":"1","volume":"6","author":"A Boisson","year":"2022","unstructured":"Boisson A, Morgan CE, Fried B, Shea CM, Yotebieng M, Ngimbi P, et al. Barriers and facilitators to timely birth-dose vaccines in Kinshasa Province, the DRC: a qualitative study. J Glob Health Rep. 2022;6:1\u201313.","journal-title":"J Glob Health Rep"},{"key":"338_CR18","unstructured":"World Health Organisation (WHO). National Immunization Schedule Democratic Republic of the Congo. 2018."},{"issue":"8","key":"338_CR19","first-page":"480","volume":"55","author":"AR Sarker","year":"2019","unstructured":"Sarker AR, Akram R, Ali N, Chowdhury ZI, Sultana M. Coverage and determinants of full immunization: vaccination coverage among senegalese children. Medicina (Lithuania). 2019;55(8):480.","journal-title":"Medicina (Lithuania)."},{"issue":"1","key":"338_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-017-2253-9","volume":"17","author":"M Yotebieng","year":"2017","unstructured":"Yotebieng M, Behets F, Kawende B, Ravelomanana NLR, Tabala M, Okitolonda EW. Continuous quality improvement interventions to improve long-term outcomes of antiretroviral therapy in women who initiated therapy during pregnancy or breastfeeding in the Democratic Republic of Congo: Design of an open-label, parallel, group randomized. BMC Health Serv Res. 2017;17(1):1\u20137.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"338_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10995-016-2201-z","volume":"21","author":"PN Zivich","year":"2017","unstructured":"Zivich PN, Kiketa L, Kawende B, Lapika B, Yotebieng M. Vaccination coverage and timelines among children 0\u20136 months in Kinshasa, the Democratic Republic of Congo: a prospective cohort study. Matern Child Health J. 2017;21(5):1055\u201364.","journal-title":"Matern Child Health J"},{"issue":"5","key":"338_CR22","doi-asserted-by":"publisher","first-page":"e37905","DOI":"10.1371\/journal.pone.0037905","volume":"7","author":"CS Wiysonge","year":"2012","unstructured":"Wiysonge CS, Uthman OA, Ndumbe PM, Hussey GD. Individual and contextual factors associated with low childhood immunisation coverage in Sub-Saharan Africa: a multilevel analysis. PLoS ONE. 2012;7(5):e37905.","journal-title":"PLoS ONE"},{"key":"338_CR23","unstructured":"World Health Organization (WHO). Reference Manual: Service Availability and Readiness Assessment (SARA): an annual monitoring system for service delivery. 2015."},{"key":"338_CR24","unstructured":"World Health Organization. Immunization Data portal. 2020 [cited 2021 Dec 20]. Hepatitis B Birth Dose vacination coverage. https:\/\/www.who.int\/data\/immunization"},{"issue":"1","key":"338_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgh-2021-007462","volume":"7","author":"S Lancione","year":"2022","unstructured":"Lancione S, Alvarez JV, Alsdurf H, Pai M, Zwerling AA. Tracking changes in national BCG vaccination policies and practices using the BCG World Atlas. BMJ Glob Health. 2022;7(1):1\u20138.","journal-title":"BMJ Glob Health"},{"issue":"29","key":"338_CR26","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1016\/j.vaccine.2018.05.116","volume":"36","author":"DE Phillips","year":"2018","unstructured":"Phillips DE, Dieleman JL, Shearer JC, Lim SS. Childhood vaccines in Uganda and Zambia: determinants and barriers to vaccine coverage. Vaccine. 2018;36(29):4236\u201344.","journal-title":"Vaccine"},{"issue":"27","key":"338_CR27","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1016\/j.vaccine.2019.05.023","volume":"37","author":"A Levin","year":"2019","unstructured":"Levin A, Munthali S, Vodungbo V, Rukhadze N, Maitra K, Ashagari T, et al. Scope and magnitude of private sector financing and provision of immunization in Benin, Malawi and Georgia. Vaccine. 2019;37(27):3568\u201375.","journal-title":"Vaccine"},{"issue":"8","key":"338_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/20786204.2007.10873611","volume":"49","author":"A Ibnouf","year":"2007","unstructured":"Ibnouf A, Van den Borne H, Maarse J. Factors influencing immunisation coverage among children under five years of age in Khartoum State, Sudan. South Afr Family Pract. 2007;49(8):14\u201314f.","journal-title":"South Afr Family Pract"},{"issue":"1","key":"338_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3329\/jhpn.v31i1.14756","volume":"31","author":"E Bbaale","year":"2013","unstructured":"Bbaale E. Factors influencing childhood immunization in Uganda. J Health Popul Nutr. 2013;31(1):118\u201327.","journal-title":"J Health Popul Nutr"},{"issue":"1","key":"338_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2307\/3004028","volume":"35","author":"S Desai","year":"1998","unstructured":"Desai S, Alva S. Maternal education and child health: Is there a strong causal relationship? Demography. 1998;35(1):71\u201381.","journal-title":"Demography"},{"issue":"Supp 3","key":"338_CR31","first-page":"7","volume":"27","author":"GN Mwamba","year":"2017","unstructured":"Mwamba GN, Yoloyolo N, Masembe Y, Nsambu MN, Nzuzi C, Tshekoya P, et al. Vaccination coverage and factors influencing routine vaccination status in 12 high risk health zones in the Province of Kinshasa City, Democratic Republic of Congo (DRC), 2015. The PanAfrican Medical journal. 2017;27(Supp 3):7.","journal-title":"The PanAfrican Medical journal"},{"issue":"Suppl 1","key":"338_CR32","first-page":"1","volume":"38","author":"Y Berhanel","year":"2000","unstructured":"Berhanel Y, Bekele A, Tesfaye F. Immunization (EPI) in Ethiopia: acceptance, coverage, and sustainability. Ethiop Med J. 2000;38(Suppl 1):1\u201360.","journal-title":"Ethiop Med J"},{"issue":"2","key":"338_CR33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4269\/ajtmh.16-0287","volume":"96","author":"TA Shindano","year":"2017","unstructured":"Shindano TA, Bahizire E, Fiasse R, Horsmans Y. Knowledge, attitudes, and practices of health-care workers about viral hepatitis b and C in South Kivu. Am J Trop Med Hyg. 2017;96(2):400\u20134.","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"338_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000450","volume":"2","author":"S Thahir","year":"2022","unstructured":"Thahir S, Tulenko SE, Ngimbi P, Ntambua S, Matondo J, Mwandagalirwa K, et al. Low knowledge about hepatitis B prevention among pregnant women in Kinshasa, Democratic Republic of Congo. PLOS Global Public Health. 2022;2(9): e0000450.","journal-title":"PLOS Global Public Health"},{"issue":"12","key":"338_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2016-015790","volume":"7","author":"P Herliana","year":"2017","unstructured":"Herliana P, Douiri A. Determinants of immunisation coverage of children aged 12\u201359 months in Indonesia: a cross-sectional study. BMJ Open. 2017;7(12):1\u201314.","journal-title":"BMJ Open"},{"issue":"1","key":"338_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-021-00581-9","volume":"79","author":"SM Fenta","year":"2021","unstructured":"Fenta SM, Fenta HM. Individual and community-level determinants of childhood vaccination in Ethiopia. Arch Public Health. 2021;79(1):1\u201311.","journal-title":"Arch Public Health"},{"key":"338_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.actatropica.2015.06.007","volume":"149","author":"M Lanaspa","year":"2015","unstructured":"Lanaspa M, Balcells R, Sacoor C, Nhama A, Aponte JJ, Bassat Q. The performance of the expanded programme on immunization in a rural area of Mozambique. Acta Trop. 2015;149:262\u20136.","journal-title":"Acta Trop"},{"issue":"SI1","key":"338_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29245\/2578-3009\/2018\/si.1104","volume":"2","author":"E Moturi","year":"2018","unstructured":"Moturi E, Tevi-Benissan C, Hagan J, Shendale S, Mayenga D, Murokora D, et al. Implementing a birth dose of hepatitis B vaccine in Africa: findings from assessments in 5 countries. J Immunol Sci. 2018;2(SI1):31\u201340.","journal-title":"J Immunol Sci"},{"issue":"6","key":"338_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2018-025503","volume":"9","author":"CA Adjei","year":"2019","unstructured":"Adjei CA, Stutterheim SE, Naab F, Ruiter RAC. Chronic Hepatitis B stigma in Ghana: a qualitative study with patients and providers. BMJ Open. 2019;9(6):1\u201312.","journal-title":"BMJ Open"},{"issue":"1","key":"338_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-11466-5","volume":"21","author":"AN Galadima","year":"2021","unstructured":"Galadima AN, Zulkefli NAM, Said SM, Ahmad N. Factors influencing childhood immunisation uptake in Africa: a systematic review. BMC Public Health. 2021;21(1):1\u201320.","journal-title":"BMC Public Health"},{"key":"338_CR41","first-page":"1","volume":"21","author":"P Thompson","year":"2021","unstructured":"Thompson P, Morgan CE, Ngimbi P, Mwandagalirwa K, Ravelomanana NLR, Tabala M, et al. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study. Lancet Glob Health. 2021;21:1\u201310.","journal-title":"Lancet Glob Health"}],"container-title":["Global Health Research and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41256-023-00338-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41256-023-00338-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41256-023-00338-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:27:02Z","timestamp":1768404422000},"score":1,"resource":{"primary":{"URL":"https:\/\/ghrp.biomedcentral.com\/articles\/10.1186\/s41256-023-00338-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["338"],"URL":"https:\/\/doi.org\/10.1186\/s41256-023-00338-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2264539\/v1","asserted-by":"object"}]},"ISSN":["2397-0642"],"issn-type":[{"value":"2397-0642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Boards at UNC-Chapel Hill and the Kinshasa School of Public Health approved the study protocol [UNC IRB 21\u20130014; KSPH IRB 0001 1\u201304101-00001365292\u201320]. Participants provided their written, informed consent to participate in the parent study. The parent study was approved by the IRB at Ohio State University, Albert Einstein College of Medicine, and Kinshasa School of Public Health [OSU IRB 2015H0440; Einstein IRB 2020\u201312018]. Data from the parent study were de-identified prior to analysis and all data were stored on a secure server.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PT receives research support from ASTMH\/Burroughs-Wellcome Fund, Merck, Gilead Sciences and Abbott Laboratories, outside of this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}